Here, we have therefore studied activation (CD38, HLA-DR, and Ki67) and maturation (CD27) marker profiles on IFNγ+ MTB-specific CD4 T cells in subjects with LTBI, and in aTB patients (25) before and after TB treatment initiation in comparison to the mycobacteriological treatment response. The gene discussed is CD38; the disease is tuberculosis.